AKT1 and glioblastoma: Next, we performed rescue experiments using the AKT agonist SC79, and we observed that SC79 reversed the fatostatin-induced decrease in p-AKT, p-mTOR, p-4EBP1, and GPX4 protein expression in both GBM cell lines (Fig. 5G, H).